Cargando…

Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids

Introduction. Ankaferd hemostat (ABS) is the first topical haemostatic agent involving the red blood cell-fibrinogen interactions. The antihemorrhagic efficacy of ABS has been tested in controlled clinical trials. The drug induces the formation of an encapsulated complex protein web with vital eryth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koluman, Ahmet, Akar, Nejat, Malkan, Umit Y., Haznedaroglu, Ibrahim C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746270/ https://www.ncbi.nlm.nih.gov/pubmed/26925418 http://dx.doi.org/10.1155/2016/8957820

Ejemplares similares

Effects of Ankaferd Hemostat on Helicobacter pylori strains and antibiotic resistance
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

Antineoplastic Effects of Ankaferd Hemostat
por: Malkan, Umit Yavuz, et al.
Publicado: (2022)

Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases
por: Koluman, Ahmet, et al.
Publicado: (2017)

Endothelial Cells, Ankaferd Hemostat, and Estradiol
por: Ardıçoğlu, Yasemin, et al.
Publicado: (2016)

Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper)
por: Ciftciler, Rafiye, et al.
Publicado: (2020)

Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
por: Turk, Seyhan, et al.
Publicado: (2017)

Ankaferd hemostat: from molecules to medicine
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2020)

The Antithrombin Effect of Ankaferd Hemostat (ABS) Is Related to the High Iron Content of the Medicine
por: Okay, Mufide, et al.
Publicado: (2019)

Antiinfective and wound-healing pleiotropic actions of Ankaferd hemostat
por: HAZNEDAROĞLU, İbrahim Celalettin, et al.
Publicado: (2020)

Effects of Ankaferd Hemostat on red blood cell aggregation: a hemorheological study
por: ÇİFTÇİLER, Rafiye, et al.
Publicado: (2019)

The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge
por: Karabıyık, Afife, et al.
Publicado: (2012)

A New Candidate as a Hemostatic Agent for Difficult Situations During Variceal Bleeding: Ankaferd Blood Stopper
por: Ozaslan, Ersan, et al.
Publicado: (2011)

Ankaferd hemostat (ABS) as a potential mucosal topical agent for the management of COVID-19 syndrome based on its PAR-1 inhibitory effect and oestrogen content
por: Beyazit, Fatma, et al.
Publicado: (2020)

Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper
por: Simsek, Cem, et al.
Publicado: (2017)

Analysis of the Antiproliferative Effect of Ankaferd Hemostat on Caco-2 Colon Cancer Cells via LC/MS Shotgun Proteomics Approach
por: Koçak, Engin, et al.
Publicado: (2019)

In Vitro Efficacy of the Ankaferd Galenic Hemostatic Extract as a Germicidal Agent
por: METİN, Bayram, et al.
Publicado: (2016)

Ultrastructural analyses of the novel chimeric hemostatic agent generated via nanotechnology, ABS nanohemostat, at the renal tissue level
por: Huri, Emre, et al.
Publicado: (2016)

Generation of Chimeric “ABS Nanohemostat” Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model
por: Huri, Emre, et al.
Publicado: (2013)

Oral High-Dose Ankaferd Administration Effects on Gastrointestinal System
por: Akbal, Erdem, et al.
Publicado: (2013)

Effect of the plant-based hemostatic agent Ankaferd Blood Stopper® on the biocompatibility of mineral trioxide aggregate
por: Dinçol, Muzaffer Emir, et al.
Publicado: (2016)

Discontinuation of Imatinib Mesylate could Improve Renal Impairment in Chronic Myeloid Leukemia
por: Malkan, Umit Y., et al.
Publicado: (2018)

Comparison of hemostatic efficacy of topical Ankaferd Blood Stopper on heparinized and nonheparinized rats in bleeding related to liver injury
por: Ergin, Metin, et al.
Publicado: (2021)

Treatment of pyoderma gangrenosum with thalidomide in a myelodysplastic syndrome case
por: Malkan, Umit Yavuz, et al.
Publicado: (2016)

Analysing the blood-stemming effect of Ankaferd Blood Stopper in medulla spinalis surgery
por: TÜRKÖZ, Dursun, et al.
Publicado: (2020)

Effect of ankaferd blood stopper in experimental peritoneal adhesion model
por: Karaca, Gokhan, et al.
Publicado: (2016)

Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Demonstration of the histopathological and immunohistochemical effects of a novel hemostatic agent, ankaferd blood stopper, on vascular tissue in a rat aortic bleeding model
por: Kandemir, Ozer, et al.
Publicado: (2010)

The Effectiveness of a New Hemostatic Agent (Ankaferd Blood Stopper) for the Control of Bleeding following Tooth Extraction in Hemophilia: A Controlled Clinical Trial
por: Kazancıoğlu, Hakkı Oğuz, et al.
Publicado: (2013)

In vitro analysis of the renin–angiotensin system and inflammatory gene transcripts in human bronchial epithelial cells after infection with severe acute respiratory syndrome coronavirus
por: Turk, Can, et al.
Publicado: (2020)

Effects of Ankaferd BloodStopper on bone healing in an ovariectomized osteoporotic rat model
por: Ezirganli, Şeref, et al.
Publicado: (2017)

The Factors Affecting Early Death in Newly Diagnosed APL Patients
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

NK-cell dysfunction of acute myeloid leukemia in relation to the renin–angiotensin system and neurotransmitter genes
por: Turk, Seyhan, et al.
Publicado: (2022)

Comment on Zamfir et al. Hematologic Malignancies Diagnosed in the Context of the mRNA COVID-19 Vaccination Campaign: A Report of Two Cases. Medicina 2022, 58, 874
por: Çınar, Olgu Erkin, et al.
Publicado: (2022)

Indications and Outcomes of Splenectomy for Hematological Disorders
por: Ciftciler, Rafiye, et al.
Publicado: (2019)

Assessment of the efficacy of Ankaferd blood stopper on the prevention of postoperative pericardial adhesions
por: Nazli, Yunus, et al.
Publicado: (2014)

Assessment of Ankaferd Blood Stopper in experimental liver ischemia reperfusion injury
por: DURHAN, Abdullah, et al.
Publicado: (2020)

The effect of Ankaferd blood stopper on liver damage in experimental obstructive jaundice
por: KOŞMAZ, Koray, et al.
Publicado: (2021)

Drug interaction potential of Ankaferd blood stopper(®) in human hepatocarcinoma cells
por: SEMİZ, Aslı
Publicado: (2022)

Experimental Investigation of the Effects of a Blood Stopper Agent (Ankaferd Blood Stopper) on Bone Surfaces
por: Şimşek, Hasan Onur, et al.
Publicado: (2013)

An evaluation of the effects of caffeic acid phenethyl ester and Ankaferd blood stopper on secondary wound healing of oral mucosal tissue
por: GÜL, Mehmet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9pee4audslck2lvd7742sn4ela